MAGEA3 antibody (AA 216-265)
Quick Overview for MAGEA3 antibody (AA 216-265) (ABIN604749)
Target
See all MAGEA3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 216-265
-
Brand
- IHC-plus™
-
Specificity
- Human MAGEA3
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa216-265 of human MAGEA3 (P43357, NP_005353). Percent identity by BLAST analysis: Human, Gorilla (100%), Gibbon (92%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
-
Approved: IHC, IHC-P (5 μg/mL), WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- MAGEA3 (Melanoma Antigen Family A, 3 (MAGEA3))
-
Alternative Name
- MAGEA3
-
Background
-
Name/Gene ID: MAGEA3
Synonyms: MAGEA3, Antigen MZ2-D, Cancer/testis antigen 1.3, CT1.3, HYPD, MAGE-3 antigen, Melanoma-associated antigen 3, HIP8, MAGE3, Melanoma antigen family A, 3 -
Gene ID
- 4102
-
NCBI Accession
- NP_005353
-
UniProt
- P43357
Target
-